Close

USPTO Genetic Testing Study: BIO's Testimony

<p>
<span style="font-size: 14.3999996185303px; line-height: 24.4799995422363px;">If a poor patient in Nevada doesn&rsquo;t have access to an advanced molecular diagnostic test, and right across the border in California a similar patient has access to the same test, there&rsquo;s obviously something wrong with that, but how can that be a patent problem?</span></p>

If a poor patient in Nevada doesn’t have access to an advanced molecular diagnostic test, and right across the border in California a similar patient has access to the same test, there’s obviously something wrong with that, but how can that be a patent problem? How can it be a patent problem in Nevada and not a patent problem in California? That’s not how we understand patents to operate - inescapably, there’s something else at work here. 

Read the Testimony